Publikasi

Light-Controlled Gene Expression Platform Reportedly Do...

The real opportunity lies in next generation complex biologics such as multispec...

CoCoGraph AI Model Generates Molecules that Comply with...

Discovering viable new molecules is challenging due to the vastness of the searc...

Regulators Should Rely on Peers’ GMP Audits to Cut Insp...

Duplicate GMP inspections are a major challenge for biopharmaceutical manufactur...

Moss Powering the Next Drug Frontier

A humble moss is emerging as a powerful biomanufacturing platform for hard-to-ma...

Researchers’ Spinout Focuses on Simplifying Viral Vecto...

A new company is offering peptide ligands for purifying viral vectors for gene t...

Heavy-Chain BsAbs More Manufacturable than Light-Chains

Bispecific antibodies are considered difficult to produce, especially at scale. ...

The First All Adrenal Issue

There’s something fun about “firsts” with such a well-established publication li...

Online booking app dubbed ‘the Uber of dental appointme...

A web app which connects patients to available dental appointments has been comp...

Novelty Nobility Expands AGC Biologics Deal to Take Pro...

The project leverages AGC Biologics’ global network, having completed cell line ...

‘Decision fatigue’ in hospitalists: What’s the biggest ...

High patient volume may be a bigger driver of “decision fatigue” in hospitalists...

Citius raises $36.5m for Lymphir commercialisation

The therapy is approved by the US Food and Drug Administration (FDA) for adult p...

MSD concludes Terns acquisition to expand CML pipeline

Following a successful tender offer and subsequent merger, the companies announc...

Gujarat’s bet on Jambusar 

Between the Gulf of Khambhat and the Narmada, India is staking 3,920 crores on ...

Haroli: Himachal’s next pharma play 

In Haroli, a quiet industrial location is being positioned at the centre of Ind...

India’s next pharma powerhouses

India’s pharma growth is increasingly being shaped not just by companies, but b...

The next wave 

India’s next pharma leap is being built from the ground up, through a new gener...